NEW JERSEY ASSOCIATION FOR BIOMEDI… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1989

Legal Domicile

Principal Officer

DR LAURA CONOUR

Phone

6093374303

Tax Period

2024-01-01 to 2024-12-31

NEW JERSEY ASSOCIATION FOR BIOMEDICAL RESEARCH, founded in 1989, is a small nonprofit that reported $240K in total revenue in fiscal year 2024. The organization ran a surplus of $47K, a strong 20% operating margin.

Mission

TO PROMOTE PUBLIC UNDERSTANDING OF BIOMEDICAL RESEARCH IN ADVANCING HUMAN AND ANIMAL HEALTH.

Program Service Accomplishments

Program 1

Expenses: $50,057 Revenue: $72,426

EDUCATION OF PUBLIC AS TO BENEFITS DERIVED FROM BIOMEDICAL RESEARCH THROUGH ATTENDANCE AT CONVENTIONS, ADMINISTERING CITIZENS GROUPS AND SPEAKERS BUREAU, AND PUBLICATION OF NEWSLETTER.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $134,700

Program Service Revenue $72,426

Investment Income $33,336

Other Revenue $0

TOTAL REVENUE $240,462

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $50,057

Other Expenses $193,211

TOTAL EXPENSES $193,211

Year-over-Year Comparison

	2024	2023	Change
Revenue	$240,462	$243,978	0.0%
Expenses	$193,211	$206,061	-0.1%
Net Income	$47,251	$37,917	+0.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DR LAURA CONOUR	BOARD CHAIR	1.00	Officer	$0	$0	$0
TONI ALBANESE	VICE CHAIR	1.00	Officer	$0	$0	$0
VIRGINIA PLAZA	TREASURER	1.00	Officer	$0	$0	$0
DR KAREN FROBERG-FEJKO	IMM PAST PRE	1.00	Officer	$0	$0	$0
CECE BROTCHIE-FINE	DIRECTOR	0.50	Director	$0	$0	$0
DR HOLLY BURR	DIRECTOR	0.50	Director	$0	$0	$0
PAULA CLIFFORD	DIRECTOR	0.50	Director	$0	$0	$0
WILLIAM BARBO	DIRECTOR	0.50	Director	$0	$0	$0
DR STACEY CONARELLO	DIRECTOR	0.50	Director	$0	$0	$0
DR ALEX DELONG	DIRECTOR	0.50	Director	$0	$0	$0
JOHN DENIER	DIRECTOR	0.50	Director	$0	$0	$0
DR NANCY HALPERN	DIRECTOR	0.50	Director	$0	$0	$0
AMBER LANGE	DIRECTOR	0.50	Director	$0	$0	$0
DR NATALIE RAGLAND	DIRECTOR	0.50	Director	$0	$0	$0
DR BHUPINDER SINGH	DIRECTOR	0.50	Director	$0	$0	$0
KATHERINE PREGAL	DIRECTOR	0.50	Director	$0	$0	$0
PAMELA STRAETER	DIRECTOR	0.50	Director	$0	$0	$0
DR RAJU TAMOT	DIRECTOR	0.50	Director	$0	$0	$0
SCOTT MARSHALL	DIRECTOR	0.50	Director	$0	$0	$0
JEFF WEIDLICK	DIRECTOR	0.50	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$240,462	$193,211	$495,522	$47,251
2023	$243,978	$206,061	$443,076	$37,917
2022	$180,468	$156,983	$422,590	$23,485
2021	$179,812	$168,952	$468,818	$10,860

NEW JERSEY ASSOCIATION FOR BIOMEDICAL RESEARCH